Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-000128
Filing Date
2023-02-14
Accepted
2023-02-14 13:48:56
Documents
65
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q novaccess20221231_10q.htm   iXBRL 10-Q 722207
2 EXHIBIT 31.1 ex_472501.htm EX-31.1 8493
3 EXHIBIT 31.2 ex_472502.htm EX-31.2 8469
4 EXHIBIT 32.1 ex_472503.htm EX-32.1 3614
  Complete submission text file 0001185185-23-000128.txt   4844182

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20221231.xsd EX-101.SCH 48860
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xsnx-20221231_cal.xml EX-101.CAL 24479
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20221231_def.xml EX-101.DEF 253424
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20221231_lab.xml EX-101.LAB 400314
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20221231_pre.xml EX-101.PRE 262044
59 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20221231_10q_htm.xml XML 596628
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

EIN.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-29621 | Film No.: 23626694
SIC: 2834 Pharmaceutical Preparations